Primary lung cancer and TNF-α gene polymorphisms: A case-control study in a Croatian population

Medical Science Monitor

Volumn 15, Issue 7, 2009, Pages

  Flego, Veljko ^a   Badovinac, Andjelka Radojčić ^b   Bulat Kardum, Ljiljana ^a   Matanić, Dubravka ^a   Crnić Martinović, Marija ^a   Kapović, Miljenko ^b   Ristić, Smiljana ^b  

^a KBC RIJEKA   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Cancer susceptibility; Caucasian population; Lung cancer; TNF polymorphism; Tumor stage; Tumor type

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROATIA; DISEASE SEVERITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LUNG CANCER; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; TNF ALPHA 238 GENE; TNF ALPHA 308 GENE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CROATIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650666395     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Remontet L, Esteve J, Bouvier AM et al: Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique, 2003; 51: 3-30
2. Cancer incidence in Croatia 2004. Bulletin no. 29. Zagreb: Croatian national institute of public health. Croatian National Cancer Registry, 2006
3. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y: EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology, 2006; 17: 89-99 (Pubitemid 43755785)
4. Kharfi A, Labelle Y, Mailloux J, Akoum A: Defi cient expression of tumor necrosis factor receptor type 2 in the endometrium of women with endometriosis. Am J Reprod Immunol, 2003; 50: 33-40 (Pubitemid 36805762)
5. Benlloch M, Mena S, Ferrer P et al: Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy. J Biol Chem, 2006; 281: 69-79 (Pubitemid 43671164)
6. Choi C, Benveniste EN: Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev, 2004; 44: 65-81 (Pubitemid 38114759)
7. Basturk B, Yavascaoglu I, Vuruskan H et al: Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Cytokine, 2005; 30: 41-45 (Pubitemid 40387354)
8. Seifart C, Plagens A, Dempfle A et al: TNF-α, TNF-β, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers, 2005; 21: 157-165